Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease
This study has been completed.
Study NCT00007033 Information provided by National Center for Research Resources (NCRR)
First Received: December 6, 2000 Last Updated: January 21, 2009
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Alagille Syndrome
Cholestasis
Biliary Atresia
Additional conditions recognized in this trial
Syndrome
More general conditions related to this trial
Abnormalities, Multiple
Bile Duct Diseases
Biliary Tract Diseases
Cardiovascular Abnormalities
Cardiovascular Diseases
Cholestasis, Intrahepatic
Congenital Abnormalities
Digestive System Abnormalities
Digestive System Diseases
Disease
Genetic Diseases, Inborn
Heart Defects, Congenital
Liver Diseases
Pathologic Processes
Interventions listed in this trial
magnesium gluconate
magnesium sulfate
More general drug interventions related to this trial
Analgesics
Anesthetics
Anti-Arrhythmia Agents
Anticonvulsants
Calcium Channel Blockers
Cardiovascular Agents
Central Nervous System Agents
Central Nervous System Depressants
Membrane Transport Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Sensory System Agents
Therapeutic Uses
Tocolytic Agents
Sponsors listed in this trial
National Center for Research Resources (NCRR)
Children's Hospital Medical Center, Cincinnati
Back to top of Main Content
